Cell Analysis Market by Instruments - JSB Market Research
Cell Analysis Market by Instruments
Published on 19th April 2014
The global cell analysis market is a technology-driven market and is marked by the Threat of Obsolescence, wherein technologies as well as their adoption by end users changes very rapidly. Hospitals, academic and government institutes, as well as pharmaceutical and biotechnology companies are increasing their focus on using cell analysis as a powerful research tool in research, drug discovery, and diagnosis. The cell analysis instruments market is the fastest-growing segment in the cell analysis market. In cell analysis, the accuracy of the results obtained depends on the quality of consumables, instruments, and data management software. In the recent years, advanced cell image analysis and data management solutions have been introduced, but there is scope for further improvement of these solutions. Many of the key players in the cell analysis instruments market are collaborating with companies and academic institutes in order to offer products with better software. For instance, in February 2014, Agilent Technologies (U.S.) collaborated with Cell Line Genetics (U.S.) for high throughput screening of cell line characterization services for regenerative medicine. Cell Line Genetics will develop high throughput, genomic characterizations to confirm and monitor the integrity of a cell line for translational and regenerative medicine research by using Agilents technologies.
Table of Content:-
1 Introduction (Page No. - 19) 1.1 Objectives Of The Study 1.2 Report Description 1.3 Markets Covered 1.4 Stakeholders 1.5 Market Scope
1.6 Research Methodology 1.6.1 Market Size Estimation 1.6.2 Market Crackdown and Data Triangulation 1.6.3 Key Data Points From Secondary Sources 1.6.4 Key Data Points From Primary Sources 1.6.5 Assumptions 2 Summary
(Page No. - 31)
On the basis of product type:
Global cell analysis market
Pharmaceutical and biotechnology companies
Published on 19th April 2014
The global cell analysis market is a technology-driven market and is marked by the Threat of Obsolescence, wherein technologies as well as their adoption by end users changes very rapidly. Hospitals, academic and government institutes, as well as pharmaceutical and biotechnology companies are increasing their focus on using cell analysis as a powerful research tool in research, drug discovery, and diagnosis. The cell analysis instruments market is the fastest-growing segment in the cell analysis market. In cell analysis, the accuracy of the results obtained depends on the quality of consumables, instruments, and data management software. In the recent years, advanced cell image analysis and data management solutions have been introduced, but there is scope for further improvement of these solutions. Many of the key players in the cell analysis instruments market are collaborating with companies and academic institutes in order to offer products with better software. For instance, in February 2014, Agilent Technologies (U.S.) collaborated with Cell Line Genetics (U.S.) for high throughput screening of cell line characterization services for regenerative medicine. Cell Line Genetics will develop high throughput, genomic characterizations to confirm and monitor the integrity of a cell line for translational and regenerative medicine research by using Agilents technologies.
Table of Content:-
1 Introduction (Page No. - 19) 1.1 Objectives Of The Study 1.2 Report Description 1.3 Markets Covered 1.4 Stakeholders 1.5 Market Scope
1.6 Research Methodology 1.6.1 Market Size Estimation 1.6.2 Market Crackdown and Data Triangulation 1.6.3 Key Data Points From Secondary Sources 1.6.4 Key Data Points From Primary Sources 1.6.5 Assumptions 2 Summary
(Page No. - 31)
On the basis of product type:
Global cell analysis market
Pharmaceutical and biotechnology companies